Tag: life science
Apr 04, 2013 07:00 CEST The European Association for the Study of Diabetes has chosen Stockholm as the site of its major conference in the autumn of 2015. The city will thus be hosting the event for the fourth time. The decision was motivated by Stockholm's good conditions and Stockholmsmässan's long experience in arranging international conferences. The region is also one of the world's leading in diabetes research.
Mar 14, 2013 08:31 CET It is going to be easier for foreign investors to find partners in Stockholm and Uppsala. Stockholm-Uppsala Life Science Investment Hotlist is now being launched, a tool presenting the region's hottest investment prospects to investors.
Feb 08, 2013 07:30 CET On February 12th 2013, the 7th annual Swiss-Scandinavian Bio-Business Seminar is being held in Zürich, Switzerland. The conference offers a unique possibility to meet Stockholm-based life sciences companies on the cutting edge. Participants include: Aberabio, Binarybio, Biolamia, Biovica, Irras, Oss-Q and Xbrane Bioscience.
Feb 13, 2013 10:30 CET Stockholm-Uppsala, Scandinavia’s leading life-science cluster, is getting increasing attention from international investors as the region's life science sector continues to go from strength to strength.
Nov 16, 2011 10:47 CET With a first-class reputation for innovation in both medical technology and mobile communication, the capital of Sweden has emerged as a front-runner in mobile healthcare.
Mar 13, 2013 10:00 CET The Stockholm-Uppsala Life Science Investment Hotlist features a carefully selected top list of investment cases from the region. Curated by Stockholm Business Region Development, the list is a tool for investors focusing on innovation from one of the world's leading life science regions.
Dec 14, 2011 10:33 CET The US continues to dominate; most venture capital goes to drug discovery platforms and the most successful companies in need of venture capital are those who most clearly fit in to investors' strategy. Despite a leading R&D position, Swedish life science companies must improve international relations to succeed in attracting investments. This emerged in a new report on corporate venture capital.
